Facebook Twitter LinkedIn Google Plus RSS

Actavis acquiring Warner Chilcott in all-stock deal

By

Parsippany-based Actavis Inc. announced today it will acquire Warner Chilcott PLC in a $5 billion stock swap that’s expected to create a specialty pharmaceuticals company with about $11 million in annual revenue.

Actavis said it will swap 0.16 of a share for each Chilcott share, valuing the Chilcott shares at about $20.08 each. The deal is expected to close by the end of the year.

The new company, Actavis PLC, will be led by the current Actavis leadership team, the company said.

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!